UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hematopoietic Progenitors Express Neural Genes

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.14926-14931

2003

Volltextzugriff (PDF)

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology, 2007-07, Vol.69 (1), p.91-102

2007

Volltextzugriff (PDF)

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

Neurology, 2010-11, Vol.75 (22), p.2021-2027

2010

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

Increased cathepsin B activity in multiple sclerosis brain

Journal of the neurological sciences, 1995-07, Vol.131 (1), p.71-73

1995

Volltextzugriff (PDF)

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Multiple sclerosis, 2015-09, Vol.21 (10), p.1322-1331

2015

Volltextzugriff (PDF)

Short-duration robotic therapy in stroke patients with severe upper-limb motor impairment

Journal of rehabilitation research and development, 2005-09, Vol.42 (5), p.683-692

2005

Volltextzugriff (PDF)

Clinical trials of interferons in multiple sclerosis what have we learned?

Journal of neuroimmunology, 1993-07, Vol.46 (1), p.155-164

1993

Volltextzugriff (PDF)

Interferon- γ induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription

Journal of neuroimmunology, 1997-04, Vol.74 (1), p.77-84

1997

Volltextzugriff (PDF)

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Multiple sclerosis, 1995-11, Vol.1 (3), p.165-169

1995

Volltextzugriff (PDF)

Robotic upper-limb neurorehabilitation in chronic stroke patients

Journal of rehabilitation research and development, 2005-11, Vol.42 (6), p.717-722

2005

Volltextzugriff (PDF)

Endotoxin Induces Increased Intracellular Cathepsin B Activity in THP-1 Cells

Immunopharmacology and immunotoxicology, 1997-01, Vol.19 (2), p.215-237

1997

Volltextzugriff (PDF)

The cost of delaying treatment in multiple sclerosis: what is lost is not regained

Neurology, 2001-06, Vol.56 (12), p.1620-1620

2001

Volltextzugriff (PDF)

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years

Neurology, 1996-10, Vol.47 (4), p.889-894

1996

Volltextzugriff (PDF)

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Neurology, 1994-06, Vol.44 (6), p.1054-1054

1994

Volltextzugriff (PDF)

Gamma Interferon Induced Increases in Intracellular Cathepsin B Activity in PMA Primed Thp-1 Cells are Blocked by Inhibitors of Protein Kinase C

Immunopharmacology and immunotoxicology, 1996-01, Vol.18 (3), p.375-396

1996

Volltextzugriff (PDF)

Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?

Neurology, 2003-01, Vol.60 (1), p.6-7

2003

Volltextzugriff (PDF)

The current status of studies of aminopyridines in patients with multiple sclerosis

Annals of neurology, 1994, Vol.36 (S1), p.S118-S121

Bever Jr, Christopher T.

1994

Volltextzugriff (PDF)

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Neurology, 1996-12, Vol.47 (6), p.1457-1462

1996

Volltextzugriff (PDF)

Glatiramer acetate inhibition of tumor necrosis factor‐α‐induced RANTES expression and release from U‐251 MG human astrocytic cells

Journal of neurochemistry, 2001-06, Vol.77 (5), p.1208-1217

2001

Volltextzugriff (PDF)

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Neurology, 1996-06, Vol.46 (6), p.1639-1643

1996

Volltextzugriff (PDF)

Activation of astrocytic lysosomal proteinases by factors released by mononuclear leukocytes

Neurochemical research, 1989, Vol.14 (1), p.37-41

1989

Volltextzugriff (PDF)

Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

Neurology, 1999-10, Vol.53 (7), p.1380-1380

1999

Volltextzugriff (PDF)

Determinants of 4-Aminopyridine Sensitivity in a Human Brain Kv1.4 K+ Channel: Phenylalanine Substitutions in Leucine Heptad Repeat Region Stabilize Channel Closed State

Molecular pharmacology, 2002-04, Vol.61 (4), p.913-920

2002

Volltextzugriff (PDF)

Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription

Neurochemical research, 2001-02, Vol.26 (2), p.125-133

2001

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hematopoietic Progenitors Express Neural Genes

Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Increased cathepsin B activity in multiple sclerosis brain

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Short-duration robotic therapy in stroke patients with severe upper-limb motor impairment

Clinical trials of interferons in multiple sclerosis what have we learned?

Interferon- γ induced increases in intracellular cathepsin B activity in THP-1 cells are dependent on RNA transcription

The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study

Robotic upper-limb neurorehabilitation in chronic stroke patients

Endotoxin Induces Increased Intracellular Cathepsin B Activity in THP-1 Cells

The cost of delaying treatment in multiple sclerosis: what is lost is not regained

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Gamma Interferon Induced Increases in Intracellular Cathepsin B Activity in PMA Primed Thp-1 Cells are Blocked by Inhibitors of Protein Kinase C

Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis?

The current status of studies of aminopyridines in patients with multiple sclerosis

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

Glatiramer acetate inhibition of tumor necrosis factor‐α‐induced RANTES expression and release from U‐251 MG human astrocytic cells

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Activation of astrocytic lysosomal proteinases by factors released by mononuclear leukocytes

Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

Determinants of 4-Aminopyridine Sensitivity in a Human Brain Kv1.4 K+ Channel: Phenylalanine Substitutions in Leucine Heptad Repeat Region Stabilize Channel Closed State

Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription

Suchergebnisse filtern